No Data
Teva Pharmaceuticals Schizophrenia Drug Delivery Trial Shows Improvement in Social Functioning
Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 From the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Express News | Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 From the Impact-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements In Social Functioning And Quality Of Life In Adults Receiving TEV-'749, A Subcutaneous Long-Acting Injectable As Well As Results...
Countdown to the USA election, when will the results be announced? Please keep this viewing guide handy!
"The big show" is about to begin, grab your "program."
Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
No Data
No Data
